Finance

Lists
A58:ETR
Elevance Health Inc
381,40 €
-0,63%
(-2,40) 1D
16 հոկ, 09:04:44 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for A58...
Open
381,40 €
High
381,40 €
Low
381,40 €
Mkt. cap
92,23 մլրդ
Avg. vol.
12,00
Volume
0,00
52-wk high
382,50 €
52-wk low
241,60 €
No. of employees
97 հզր
Open
381,40 €
High
381,40 €
Low
381,40 €
Mkt. cap
92,23 մլրդ
Avg. vol.
12,00
Volume
0,00
52-wk high
382,50 €
52-wk low
241,60 €
No. of employees
97 հզր
News stories
From web sources and news partners
Profile
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
About Elevance Health Inc
CEOGail Koziara Boudreaux
Employees96,6 հզր
Founded1944
HeadquartersԻնդիանապոլիս, Ինդիանա, Միացյալ Նահանգներ
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
50,71 մլրդ
49,75 մլրդ
50,18 մլրդ
50,47 մլրդ
Cost of goods sold
38,14 մլրդ
38,06 մլրդ
35,62 մլրդ
37,02 մլրդ
Cost of revenue
38,14 մլրդ
38,06 մլրդ
35,62 մլրդ
37,02 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,65 մլրդ
10,75 մլրդ
11,79 մլրդ
11,04 մլրդ
Operating expense
10,81 մլրդ
10,92 մլրդ
11,90 մլրդ
11,15 մլրդ
Total operating expenses
48,95 մլրդ
48,98 մլրդ
47,52 մլրդ
48,17 մլրդ
Operating income
1,76 մլրդ
766,00 մլն
2,66 մլրդ
2,30 մլրդ
Other non operating income
-
-
-
-
EBT including unusual items
1,41 մլրդ
215,00 մլն
2,30 մլրդ
1,94 մլրդ
EBT excluding unusual items
1,41 մլրդ
399,00 մլն
2,30 մլրդ
1,94 մլրդ
Income tax expense
219,00 մլն
-331,00 մլն
544,00 մլն
483,00 մլն
Effective tax rate
15,58%
-153,95%
23,61%
24,94%
Other operating expenses
-
-
-
-
Net income
1,19 մլրդ
547,00 մլն
1,76 մլրդ
1,46 մլրդ
Net profit margin
2,34%
1,10%
3,52%
2,90%
Earnings per share
6,03
3,33
12,58
7,45
Interest and investment income
-
-
-
-
Interest expense
-351,00 մլն
-367,00 մլն
-357,00 մլն
-364,00 մլն
Net interest expenses
-351,00 մլն
-367,00 մլն
-357,00 մլն
-364,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
2,14 մլրդ
1,17 մլրդ
3,02 մլրդ
2,67 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps